Literature DB >> 23887283

Prognostic impact of lymph node involvement and the extent of lymphadenectomy (LAD) in adenocarcinoma of the esophagogastric junction (AEG).

Leila Sisic1, Susanne Blank, Wilko Weichert, Dirk Jäger, Christoph Springfeld, Marcel Hochreiter, Markus Büchler, Katja Ott.   

Abstract

BACKGROUND: The prognostic importance of lymph node (LN) involvement for patients with adenocarcinoma of the esophagogastric junction (AEG) is well-known. In the latest edition of the UICC staging system, the number of metastatic LNs was taken into account, while the extent of lymphadenectomy (LAD) remains unaddressed. Removal of at least six LNs is recommended, but there is no defined minimum number as to classify as (y)pN0. We examined the prognostic value of the number of positive LNs, number of LNs removed, and LN ratio (LNR) in order to determine the influence of an adequate LAD on overall survival (OS).
METHODS: We analyzed data of 316 patients with AEG treated in our institution (2001-2011) regarding clinicopathological data, treatment, morbidity, mortality, and long-term prognosis. Univariate and multivariate analysis was performed using Cox regression to evaluate the prognostic impact of(y)pN category, number of LNs removed and LNR.
RESULTS: OS decreased with higher count of positive LNs (p < 0.001) and higher LNR (p < 0.001). Whether >6, >15, or >30 LNs were removed did not influence OS, neither in the entire study population nor within individual (y)pT or (y)pN categories. Multivariate analysis revealed LNR (p < 0.001) besides M category (p = 0.015) and tracheotomy during the postoperative course (p = 0.005) as independent predictors of OS.
CONCLUSION: The classification according to the number of involved LNs in the latest edition of the UICC staging system improves prognostication in patients with AEG. The importance of an adequate LAD is shown by the high prognostic relevance of the LNR rather than the absolute number of LNs removed.

Entities:  

Mesh:

Year:  2013        PMID: 23887283     DOI: 10.1007/s00423-013-1101-6

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  40 in total

1.  Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.

Authors:  Jeffrey Rentz; David Bull; David Harpole; Stephen Bailey; Leigh Neumayer; Theodore Pappas; Barbara Krasnicka; William Henderson; Jennifer Daley; Shukri Khuri
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

2.  The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system.

Authors:  Nabil Rizk; Ennapadam Venkatraman; Bernard Park; Raja Flores; Manjit S Bains; Valerie Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2006-12       Impact factor: 5.209

3.  Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer.

Authors:  Johanna W van Sandick; J Jan B van Lanschot; Fiebo J W ten Kate; Jan G P Tijssen; Hugo Obertop
Journal:  J Am Coll Surg       Date:  2002-01       Impact factor: 6.113

4.  Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Authors:  Thomas W Rice; Valerie W Rusch; Hemant Ishwaran; Eugene H Blackstone
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

5.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

6.  Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.

Authors:  Katja Ott; Franz G Bader; Florian Lordick; Marcus Feith; Holger Bartels; J Ruediger Siewert
Journal:  Ann Surg Oncol       Date:  2009-02-03       Impact factor: 5.344

7.  Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction: a population-based analysis.

Authors:  Eero I T Sihvo; Markku E Luostarinen; Jarmo A Salo
Journal:  Am J Gastroenterol       Date:  2004-03       Impact factor: 10.864

8.  Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Authors:  Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Juan P Wisnivesky
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

9.  Total number of resected lymph nodes predicts survival in esophageal cancer.

Authors:  Nasser K Altorki; Xi Kathy Zhou; Brendon Stiles; Jeffrey L Port; Subroto Paul; Paul C Lee; Madhu Mazumdar
Journal:  Ann Surg       Date:  2008-08       Impact factor: 12.969

10.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

View more
  12 in total

1.  Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Jian-Kun Hu
Journal:  Chin J Cancer Res       Date:  2014-06       Impact factor: 5.087

2.  Prognostic significance of lymph node ratio in esophageal cancer.

Authors:  Nana Wang; Yibin Jia; Jianbo Wang; Xintong Wang; Cihang Bao; Qingxu Song; Bingxu Tan; Yufeng Cheng
Journal:  Tumour Biol       Date:  2014-11-21

3.  Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.

Authors:  Zhangjian Zhou; Hao Zhang; Zisen Xu; Wenhan Li; Chengxue Dang; Yongchun Song
Journal:  World J Surg Oncol       Date:  2015-06-10       Impact factor: 2.754

4.  Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas.

Authors:  T Schmidt; L Sicic; S Blank; K Becker; W Weichert; T Bruckner; T Parakonthun; R Langer; M W Büchler; J-R Siewert; F Lordick; K Ott
Journal:  Br J Cancer       Date:  2014-02-25       Impact factor: 7.640

5.  Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis.

Authors:  Yuming Zhao; Shengyi Zhong; Zhenhua Li; Xiaofeng Zhu; Feima Wu; Yanxing Li
Journal:  Oncotarget       Date:  2017-07-15

6.  Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up.

Authors:  Kei Hosoda; Keishi Yamashita; Hiromitsu Moriya; Hiroaki Mieno; Masahiko Watanabe
Journal:  World J Gastroenterol       Date:  2017-04-21       Impact factor: 5.742

7.  Surgical anatomy of the supracarinal esophagus based on a minimally invasive approach: vascular and nervous anatomy and technical steps to resection and lymphadenectomy.

Authors:  Miguel A Cuesta; Nicole van der Wielen; Teus J Weijs; Ronald L A W Bleys; Suzanne S Gisbertz; Peter van Duijvendijk; Richard van Hillegersberg; Jelle P Ruurda; Mark I van Berge Henegouwen; Jennifer Straatman; Harushi Osugi; Donald L van der Peet
Journal:  Surg Endosc       Date:  2016-08-23       Impact factor: 4.584

8.  Surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction: transthoracic or transabdominal? -a single-center retrospective study.

Authors:  Zi-Feng Yang; De-Qing Wu; Jun-Jiang Wang; Xing-Yu Feng; Jia-Bin Zheng; Wei-Xian Hu; Yong Li
Journal:  Ann Transl Med       Date:  2018-12

9.  A More Extensive Lymphadenectomy Enhances Survival After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Adenocarcinoma.

Authors:  Smita Sihag; Tamar Nobel; Meier Hsu; Kay See Tan; Rebecca Carr; Yelena Y Janjigian; Laura H Tang; Abraham J Wu; Matthew J Bott; James M Isbell; Manjit S Bains; David R Jones; Daniela Molena
Journal:  Ann Surg       Date:  2020-11-17       Impact factor: 13.787

10.  Lymph node ratio-based staging system as an alternative to the current TNM staging system to assess outcome in adenocarcinoma of the esophagogastric junction after surgical resection.

Authors:  Hongdian Zhang; Xiaobin Shang; Chuangui Chen; Yongyin Gao; Xiangming Xiao; Peng Tang; Xiaofeng Duan; Mingjian Yang; Hongjing Jiang; Zhentao Yu
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.